Anaemia in pregnancy is diagnosed based on hemoglobin levels, with screening at booking and 28 weeks. Causes include iron, vitamin B12, and folate deficiencies. Symptoms may include fatigue, dizziness, and shortness of breath. Management includes dietary advice, oral iron replacement, and intravenous iron therapy. Prophylactic iron or serum ferritin checks are recommended for high-risk individuals. Daily iron intake during pregnancy is 27 mg, with supplementation once deficiency occurs. Oral iron therapy is recommended with elemental iron doses of 40-80 mg daily. Monitoring of hemoglobin levels is essential, with consideration of IV iron therapy for non-compliance, malabsorption, or poor response to oral iron. Contraindications for IV iron therapy include hypersensitivity reactions, first trimester of pregnancy, and decompensated liver disease. Ferric Derisomaltose Pharmacosmos is the IV iron preparation used. Prioritize iron infusion for pregnant individuals with Hb <100 approaching term and monitor postpartum Hb levels. Blood transfusion should be considered for moderate symptoms, with careful evaluation and exploration of alternatives. Inform patients of transfusion risks, document discussions, and maximize management at birth.